Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Livingstone Health HoldingsSGX:PRH Debt-to-Equity is 1.10 as of Mar. 2026, which is 424% above its 10-year median of 0.21. The stock has 2 warning signs investors should review. Among 565 Healthcare Providers & Services companies, Livingstone Health Holdings ranks worse than 63.89% on this metric.
A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.
The historical rank and industry rank for Livingstone Health Holdings's Debt-to-Equity or its related term are showing as below:
SGX:PRH'
s Debt-to-Equity Range Over the Past 10 Years
Min: -2.79 Med: 0.21 Max: 2.42
Current: 0.72
During the past 13 years, the highest Debt-to-Equity Ratio of Livingstone Health Holdings was 2.42. The lowest was -2.79. And the median was 0.21.
SGX:PRH's Debt-to-Equity is ranked worse than 63.89% of 565
companies
in the Healthcare Providers & Services industry
Industry Median: 0.43
vs SGX:PRH: 0.72
Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.
Livingstone Health Holdings Debt-to-Equity Related Terms
Livingstone Health Holdings Debt-to-Equity Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SGX:PRH vs HCA, THC, EHC: Debt-to-Equity Comparison
For the Medical Care Facilities subindustry, Livingstone Health Holdings's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Livingstone Health Holdings Debt-to-Equity vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Livingstone Health Holdings's Debt-to-Equity distribution charts can be found below:
* The bar in red indicates where Livingstone Health Holdings's Debt-to-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Livingstone Health Holdings (SGX:PRH) has a Debt-to-Equity of 1.10 as of Mar. 2026. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on Livingstone Health Holdings and its competitors. This is 424% above median its historical median of 0.21. According to the industry distribution chart, Livingstone Health Holdings ranks #361 out of 565 companies in the Healthcare Providers & Services industry, placing it in the top 63.9%.
Is Livingstone Health Holdings' Debt-to-Equity too high?
Livingstone Health Holdings' current Debt-to-Equity of 1.10 is 424% above median its 10-year median of 0.21. The Healthcare Providers & Services industry median Debt-to-Equity is 0.43. Livingstone Health Holdings' value of 1.10 is 155.8% above this industry median. Based on the distribution chart, Livingstone Health Holdings ranks #361 out of 565 companies in the Healthcare Providers & Services industry, which is below the industry midpoint.
How does Livingstone Health Holdings' Debt-to-Equity compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Livingstone Health Holdings ranks #361 out of 565 companies for Debt-to-Equity. This places Livingstone Health Holdings in the lower half of its industry. The industry median Debt-to-Equity is 0.43. Livingstone Health Holdings' value of 1.10 is 155.8% above this benchmark. While the company's 10-year median is 0.21 vs. the industry median of 0.43, Livingstone Health Holdings has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-Equity for a Healthcare Providers & Services company?
The median Debt-to-Equity among Healthcare Providers & Services companies is 0.43, based on 565 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-Equity significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Livingstone Health Holdings's current Debt-to-Equity of 1.10 is 155.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-Equity mean?
A high Debt-to-Equity can signal that a stock is expensive relative to its fundamentals. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on Livingstone Health Holdings and its competitors. For the Healthcare Providers & Services industry, the median Debt-to-Equity is 0.43 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Livingstone Health Holdings's current Debt-to-Equity is 1.10, which is 424% above median its own 10-year median of 0.21. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Livingstone Health Holdings stock overvalued right now?
Based on GuruFocus' analysis, Livingstone Health Holdings (SGX:PRH) is currently considered Modestly Overvalued. The stock's GF Value™ is S$0.02, compared to a current price of S$0.03 — trading 25% above its estimated fair value. The current Debt-to-Equity is 1.10, which is 424% above median its 10-year median of 0.21 and 155.8% above the Healthcare Providers & Services industry median of 0.43. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-Equity calculated?
Debt-to-Equity is calculated from a company's financial statements. For Livingstone Health Holdings (SGX:PRH), the current Debt-to-Equity is 1.10 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Livingstone Health Holdings Ltd is a Singapore-based multidisciplinary healthcare group operating clinics and medical practices across the island. Its Specialist Healthcare segment, which generates the majority of revenue, comprises specialist doctors and allied health professionals in fields such as orthopaedics, cardiology, gastroenterology, and pain management. The Primary Healthcare segment covers general practitioner and family medicine services, while the Others segment includes aesthetics and wellness, podiatry, nerve testing, healthcare consultancy, and management services. The group serves individual patients, corporate clients, and insurers through its network of clinics, with operations concentrated in Singapore. Revenue is derived mainly from patient consultation and treatment fees, specialist procedures, and related healthcare services, supplemented by management and consultancy arrangements.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SGX:PRH has been successfully added to your 
